Nano research in Asia
This article was originally published in The Tan Sheet
Executive Summary
South Korea's Institute of Machinery and Materials signs a five-year memorandum of understanding with two Singapore institutes to research and develop nanotechnologies across nine sectors that could apply in biomedicine. The Korean institute and Singapore's Institute of Materials Research and Engineering and Institute of Manufacturing Technology in the Agency for Science Technology and Research will conduct joint academic meetings, symposia, research and development projects. Pooling resources will progress platform technologies that will support the related industries. Achievements in sectors, including laser and mechanical machining, metric measurements, fluidics device manufacturing and other nano-processes topics and materials, could apply to the medical and biomedical industry, the Korean institute says. Other sectors to be studied include functional coatings, roll-to-roll printed electronics, imprint lithography, composites and green energy applications
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.